1.
Noseworthy JH ,
Lucchinetti C ,
Rodriguez M ,
Weinshenker BG .
Multiple sclerosis .
N Engl J Med 2000 ; 343 ( 13 ): 938 – 952 .
2.
Swanton JK ,
Rovira A ,
Tintore M ,
et al .
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study.
Lancet Neurol 2007; 6 (8): 677 – 686.
3.
Barkhof,
F.
“MRI in multiple sclerosis: correlation with expanded disability status scale,”1999.
Mult Scler 5(4): 283-6.
4.
Polman Ch,
Reingold SC,
Edan G,
et al.
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald criteria.” Ann Neurol 2005; 48:840–846.
5.
D Phol,
K Rostasy,
B Krone,
and F Hanefield,
Balo’s concentric sclerosis associated with primary human herpesvirus 6 infection,
J Neurol Neurosurg Psychiatry 2005; 76: 1723-1725.
6.
Hensley S,
Smirniotopoulos J.
The Central Nervous System.
In: Weidner N,
editor.
The difficult Diagnosis in Surgical Pathology.
1st ed.
Philadelphia (PA): WB Saunders; 1996.
p.879.
7.
Erana-Rojas IE,
Barboza-Quintana A,
Ayala AG,
Fuller GN.
Demyelinating Pseudotumour.
Ann Diagn Pathol 2002; 5: 265-271.
8.
Hunter SB,
Ballinger WE Jr,
Rubin JJ.
Multiple sclerosis mimicking primary brain tumor.
Arch Pathol Lab Med 1987;111:464-8.
9.
Erana-Rojas IE,
Barboza-Quintana A,
Ayala AG,
Fuller GN.
Demyelinating pseudotumor.
Ann Diagn Pathol 2002; 6:265-71.
10.
Wingerchuk DM,
Hogancamp WF,
O’Brien PC,
Weinshenker BG.
The clinical course of neuromyelitis optica (Devic’s syndrome).
Neurology 1999; 53: 1107–14.
11.
Wingerchuk DM,
Lennon VA,
Pittock SJ,
et al.
Revised diagnostic criteria for neuromyelitis optica.
Neurology 2006; 66: 1485-1489.
12.
Murthy SN,
Faden HS,
Cohen ME,
Bakshi R.
Acute disseminated encephalomyelitis in children.
Pediatrics 2002.
13.
Hynson JL,
Kornberg AJ,
Coleman LT,
Shield L,
Harvey AS,
Kean MJ.
Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children.
Neurology 2001; 56(10):1308–1312.
14.
Agarwal R,
Sze G.
Neuro-lyme disease: MR imaging findings.
Radiology.
2009 Oct;253(1):167-73.
15.
Halperin JJ,
Luft BJ,
Anand AK,
et al.
Lymeneuroborreliosis: central nervous system manifestations.
Neurology 1989; 39(6):753–759.
16.
Belman AL,
Coyle PK,
Roque C,
Cantos E.
MRI findings in children infected by Borrelia burgdorferi.
Pediatr Neurol 1992;8(6):428–431.
17.
Al-Araji A,
Kidd DP.
Neuro-Behcet’s disease: epidemiology,
clinical characteristics,
and management.
Lancet Neuro 2009;8:192–204.
18.
ACR Ad Hoc Committee of Neuropsychiatric Lupus Nomenclature.
The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.
Arthritis Rheum 1999; 42: 599-608.
19.
Jennekens FGI,
Kater L.
The central nervous system in systemic lupus erythematosus.
Part I.
Clinical syndromes: a literature investigation.
Rheumatology 2002; 41: 605-618.
20.
Alexander EL,
Provost TT,
Stevens MB,
Alexander GE.
Neurologic complications of primary Sjogren's syndrome.
Medicine (Baltimore) 1982;61:247–57.
21.
Mori K,
Iijima M,
Koike H,
Hattori N,
Tanaka F,
Watanabe H,
et al.
The wide spectrum of clinical manifestations of Sjogren's syndrome associated neuropathy.
Brain.
2005;128:2518–34.
22.
Alexander EL,
Provost TT,
Stevens MB,
Alexander GE.
Neurologic complications of primary Sjogren's syndrome.
Medicine (Baltimore) 1982;61:247–57.
23.
Diagnostic Imaging: Brain: Published by Amirsys, by Anne G.
Osborn,
Karen L.
Salzman and A.
James Barkovich (Dec 4,
2009)
24.
J.
Sanahuja et al,
“Primary Sj¨ogren’s syndrome with tumefactive central nervous system involvement,” American Journal of Neuroradiology,
vol.
29,
no.
10,
pp.
1878–1879,
2008.
25.Stern BJ,
Krumholz A,
Johns C,
Scott P,
Nissim J.
Sarcoidosis and its neurological manifestations.
Arch Neurol 1985;42:909-17.
26.
Nowak DA,Widenka DC.
Neurosarcoidosis: a review of its intracranial manifestations.
J Neurol 2001; 248:363-72.
27.
Alexander E.
Central nervous system disease in Sjogren's syndrome.
New insights into immunopathogenesis.
Rheum Dis Clin North Am.
1992;18:637–72.